简体
  • 简体中文
  • 繁体中文

热门资讯> 正文

纳斯达克(COLI:COLI)下跌0.1%

2022-07-06 14:31

Colicity Inc. (NASDAQ:COLI – Get Rating) shares traded down 0.1% during mid-day trading on Tuesday . The company traded as low as $9.79 and last traded at $9.79. 5,418 shares were traded during mid-day trading, a decline of 89% from the average session volume of 48,366 shares. The stock had previously closed at $9.80.

纳斯达克股票代码:COLI-GET Rating)股价周二午盘下跌0.1%。该公司股价低至9.79美元,最新报9.79美元。午盘成交量为5,418股,较48,366股的平均日成交量下降89%。该股此前收盘价为9.80美元。

The business has a fifty day moving average of $9.79 and a 200-day moving average of $9.76.

该业务的50日移动均线切入位在9.79美元,200日移动均线切入位在9.76美元。

Get
到达
Colicity
结肠病
alerts:
警报:

Several institutional investors and hedge funds have recently modified their holdings of COLI. Aristeia Capital LLC bought a new position in shares of Colicity in the 1st quarter worth $11,585,000. Silver Rock Financial LP bought a new position in Colicity during the 4th quarter valued at $6,818,000. Sculptor Capital LP lifted its stake in Colicity by 106.0% during the 1st quarter. Sculptor Capital LP now owns 1,134,636 shares of the company's stock valued at $11,085,000 after acquiring an additional 583,897 shares in the last quarter. P Schoenfeld Asset Management LP bought a new position in Colicity during the 1st quarter valued at $3,986,000. Finally, Saba Capital Management L.P. lifted its stake in Colicity by 200.2% during the 1st quarter. Saba Capital Management L.P. now owns 588,619 shares of the company's stock valued at $5,751,000 after acquiring an additional 392,553 shares in the last quarter. Institutional investors own 54.14% of the company's stock.

几家机构投资者和对冲基金最近调整了对Coli的持股。Aristeia Capital LLC在第一季度购买了价值11,585,000美元的Colicity股票的新头寸。Silver Rock Financial LP在第四季度购买了Colicity的新头寸,价值6818,000美元。雕塑家Capital LP在第一季度增持了106.0%的Colicity股份。雕塑家Capital LP在上个季度增持了583,897股后,现在拥有1,134,636股该公司股票,价值11,085,000美元。P Schoenfeld Asset Management LP在第一季度购买了Colicity的一个新头寸,价值3986,000美元。最后,萨巴资本管理公司在第一季度将其在Colicity的持股比例提高了200.2%。Saba Capital Management L.P.在上个季度增持了392,553股后,现在拥有588,619股该公司股票,价值5,751,000美元。机构投资者持有该公司54.14%的股份。

About Colicity
关于大肠埃希菌
(NASDAQ:COLI)
(纳斯达克:大肠杆菌)

Colicity Inc does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company intends to focus its search on identifying a prospective target business in the technology, media, and telecommunications industries in the United States and other developed countries.

Colicity Inc.没有重大业务。它侧重于实现与一个或多个企业的合并、资本换股、资产收购、股票购买、重组或类似的企业合并。该公司打算将搜索重点放在确定美国和其他发达国家的技术、媒体和电信行业的潜在目标业务上。

See Also

另请参阅

  • Get a free copy of the StockNews.com research report on Colicity (COLI)
  • Vera Bradley Stock Getting Cheap
  • 3 Education Stocks to Enroll in This Summer
  • The Institutions Get Comfortable With The Lovesac Company
  • McDonald's Might Just Be The Best Recession Proof Stock
  • Basset Furniture Quietly Proves Its Value
  • 免费获取StockNews.com关于大肠菌病的研究报告(Coli)
  • 维拉·布拉德利的股票越来越便宜
  • 3只教育类股将于今夏入围
  • 这些机构对Lovesac公司感到满意
  • 麦当劳可能就是最好的抗衰退股票
  • Basset家具悄然证明其价值

Receive News & Ratings for Colicity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colicity and related companies with MarketBeat.com's FREE daily email newsletter.

接受《Colicity Daily》的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对Colicity和相关公司的最新新闻和分析师评级的每日简要摘要。

风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。